Other
Vaginal moisturizer
Vaginal moisturizer is an intervention with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
OTHER
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
50.0%
1 of 2 finished
Non-Completion Rate
50.0%
1 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(2)
Completed(1)
Terminated(1)
Detailed Status
Completed1
Recruiting1
Withdrawn1
Not yet recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
completed125%
recruiting125%
withdrawn125%
not_yet_recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
not_yet_recruitingphase_4
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
NCT07526948
recruitingphase_4
Postpartum Vaginal Estrogen for Breastfeeding Patients
NCT05457972
completednot_applicable
Perceived Effectiveness of the Vaginal Moisturizer Investigational Product Under Normal Conditions of Use.
NCT06353945
withdrawnnot_applicable
Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia
NCT05129332
Clinical Trials (4)
Showing 4 of 4 trials
NCT07526948Phase 4
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
NCT05457972Phase 4
Postpartum Vaginal Estrogen for Breastfeeding Patients
NCT06353945Not Applicable
Perceived Effectiveness of the Vaginal Moisturizer Investigational Product Under Normal Conditions of Use.
NCT05129332Not Applicable
Vaginal Dilator Therapy Among Women With Gynecologic and Breast Cancers Experiencing Dyspareunia
All 4 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 4